Bxai in the future

本篇文章3319字，读完约8分钟

Bxiai Technology Co., Ltd. is a management group of Bxiai China (BCI). Founded in 2007, Bxiai Technology Co., Ltd. is a management oriented investment company in China. Its business covers four categories: health care, energy, real estate and Internet.

In 2013, BCI and neura link of the United States formally reached a cooperation to establish a joint-stock group company, headquartered in Washington D.C. Pennsylvania ave, focusing on the selection of high economic efficiency projects and committed to the steady growth of wealth.

The company's medical strategic partners include neuralink, white health group and Amgen / Amgen group. Now it has formed a comprehensive medical system with wide treatment coverage, rich product lines and leading technology. Its business covers high-tech research and development, drug and device production and sales, medical beauty, etc, Adhere to the European cos certification and FDA certification of drugs, and strive to promote the development of the world's medical system.

BCI health adheres to the business philosophy of "based on scientific research, patient-centered and market-oriented". It always takes innovation as the strategic focus. Through the construction of independent R & D platform, industry university research collaborative innovation and international cooperation, new products are constantly put on the market, providing guarantee for the sustainable and high-speed development of enterprises. After decades of development, has formed a set of R & D, production, sales in one, traditional Chinese medicine, chemical medicine, biological medicine, medical devices, medical cosmetology simultaneously, domestic and international market common development of medical health business model.

The brain computer interface technology developed by neuralink has entered the clinical trial stage. It is used to treat epilepsy, severe depression and even Parkinson's disease. And cooperate with the American Medical Association, strive to provide more medical institutions with a full set of hardware and software solutions of brain computer interface technology after the clinical research, so as to cure more diseases.

BCI health adheres to the business philosophy of "based on scientific research, patient-centered and market-oriented". It always takes innovation as the strategic focus. Through the construction of independent R & D platform, industry university research collaborative innovation and international cooperation, new products are constantly put on the market, providing guarantee for the sustainable and high-speed development of enterprises. After decades of development, has formed a set of R & D, production, sales in one, traditional Chinese medicine, chemical medicine, biological medicine, medical devices, medical cosmetology simultaneously, domestic and international market common development of medical health business model.

The brain computer interface technology developed by neuralink has entered the clinical trial stage. It is used to treat epilepsy, severe depression and even Parkinson's disease. And cooperate with the American Medical Association, strive to provide more medical institutions with a full set of hardware and software solutions of brain computer interface technology after the clinical research, so as to cure more diseases.